Misonix establishes HIFU clinical registry

Ultrasound technology developer Misonix has launched a global high-intensity focused ultrasound (HIFU) prostate cancer treatment clinical registry.

Designed solely for users of its Sonablate 500 (SB500) system, the registry will serve as a repository for data from centers around the world, according to the Farmingdale, NY-based firm. Data will be used to produce reports for publication in medical journals and for use in other mediums to promote SB500 as a prostate cancer treatment, the company said.

It's currently in use in Germany, and will be launched worldwide in April, Misonix said.

By AuntMinnie.com staff writers
March 27, 2007

Related Reading

Misonix reports HIFU kidney trial success, March 22, 2007

Misonix, Partnermed sign Scandinavian HIFU deal, March 6, 2007

Sonora, MDT ink joint development deal, February 20, 2007

Constantine leaves Misonix, January 9, 2007

Misonix gets new credit facility, January 4, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 512
Next Page